日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Radiological abnormalities persist following COVID-19 and correlate with impaired health-related quality of life: a prospective cohort study of hospitalised patients

COVID-19 后放射学异常持续存在,且与健康相关生活质量下降相关:一项针对住院患者的前瞻性队列研究

Sykes, Robert; Morrow, Andrew J; Mangion, Kenneth; McConnachie, Alex; McIntosh, Alasdair; Roditi, Giles; Peng, Liam; Rooney, Claire; Scott, Kathryn; Stobo, David Barrie; Berry, Colin; Church, Colin; Bayes, Hannah

Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertension

血液 DNA 甲基化分析可识别肺动脉高压中的蛋白酶 Z 失调

Anna Ulrich #, Yukyee Wu #, Harmen Draisma, John Wharton, Emilia M Swietlik, Inês Cebola, Eleni Vasilaki, Zhanna Balkhiyarova, Marjo-Riitta Jarvelin, Juha Auvinen, Karl-Heinz Herzig, J Gerry Coghlan, James Lordan, Colin Church, Luke S Howard, Joanna Pepke-Zaba, Mark Toshner, Stephen J Wort, David G

Using the Plasma Proteome for Risk Stratifying Patients with Pulmonary Arterial Hypertension

使用血浆蛋白质组对肺动脉高压患者进行风险分层

Christopher J Rhodes, John Wharton, Emilia M Swietlik, Lars Harbaum, Barbara Girerd, J Gerry Coghlan, James Lordan, Colin Church, Joanna Pepke-Zaba, Mark Toshner, Stephen J Wort, David G Kiely, Robin Condliffe, Allan Lawrie, Stefan Gräf, David Montani, Athénaïs Boucly, Olivier Sitbon, Marc Humbert, 

Mendelian randomisation and experimental medicine approaches to interleukin-6 as a drug target in pulmonary arterial hypertension

孟德尔随机化和实验医学方法将白细胞介素-6 作为肺动脉高压的药物靶点

Mark Toshner, Colin Church, Lars Harbaum, Christopher Rhodes, Sofia S Villar Moreschi, James Liley, Rowena Jones, Amit Arora, Ken Batai, Ankit A Desai, John G Coghlan, J Simon R Gibbs, Dee Gor, Stefan Gräf, Louise Harlow, Jules Hernandez-Sanchez, Luke S Howard, Marc Humbert, Jason Karnes, David G Ki

Randomised controlled trial of intravenous nafamostat mesylate in COVID pneumonitis: Phase 1b/2a experimental study to investigate safety, Pharmacokinetics and Pharmacodynamics

随机对照试验评估静脉注射萘莫司他甲磺酸盐治疗 COVID-19 肺炎的疗效:一项 1b/2a 期实验研究,旨在探讨其安全性、药代动力学和药效学。

Tom M Quinn ,Erin E Gaughan ,Annya Bruce ,Jean Antonelli ,Richard O'Connor ,Feng Li ,Sarah McNamara ,Oliver Koch ,Claire MacKintosh ,David Dockrell ,Timothy Walsh ,Kevin G Blyth ,Colin Church ,Jürgen Schwarze ,Cecilia Boz ,Asta Valanciute ,Matthew Burgess ,Philip Emanuel ,Bethany Mills ,Giulia Rinaldi ,Gareth Hardisty ,Ross Mills ,Emily Gwyer Findlay ,Sunny Jabbal ,Andrew Duncan ,Sinéad Plant ,Adam D L Marshall ,Irene Young ,Kay Russell ,Emma Scholefield ,Alastair F Nimmo ,Islom B Nazarov ,Grant C Churchill ,James S O McCullagh ,Kourosh H Ebrahimi ,Colin Ferrett ,Kate Templeton ,Steve Rannard ,Andrew Owen ,Anne Moore ,Keith Finlayson ,Manu Shankar-Hari ,John Norrie ,Richard A Parker ,Ahsan R Akram ,Daniel C Anthony ,James W Dear ,Nik Hirani ,Kevin Dhaliwal

Understanding longitudinal biventricular structural and functional changes in a pulmonary hypertension Sugen-hypoxia rat model by cardiac magnetic resonance imaging

通过心脏磁共振成像了解肺动脉高压Sugen-缺氧大鼠模型中纵向双心室结构和功能的变化

Geeshath Jayasekera, Kathryn S Wilson, Hanna Buist, Rosemary Woodward, Aysel Uckan, Colin Hughes, Margaret Nilsen, A Colin Church, Martin K Johnson, Lindsay Gallagher, James Mullin, Mandy R MacLean, William M Holmes, Andrew J Peacock, David J Welsh

Nuclear IL-33 regulates soluble ST2 receptor and IL-6 expression in primary human arterial endothelial cells and is decreased in idiopathic pulmonary arterial hypertension

核 IL-33 调节原代人动脉内皮细胞中可溶性 ST2 受体和 IL-6 的表达,并在特发性肺动脉高压中降低

Dongmin Shao, Frédéric Perros, Gaetano Caramori, Chao Meng, Peter Dormuller, Pai-Chien Chou, Colin Church, Alberto Papi, Paolo Casolari, David Welsh, Andrew Peacock, Marc Humbert, Ian M Adcock, Stephen J Wort